These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 9550474

  • 1. Soluble Fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis.
    Hashimoto H, Tanaka M, Suda T, Tomita T, Hayashida K, Takeuchi E, Kaneko M, Takano H, Nagata S, Ochi T.
    Arthritis Rheum; 1998 Apr; 41(4):657-62. PubMed ID: 9550474
    [Abstract] [Full Text] [Related]

  • 2. Stromelysin-1 (MMP-3) in synovial fluid of patients with rheumatoid arthritis has potential to cleave membrane bound Fas ligand.
    Matsuno H, Yudoh K, Watanabe Y, Nakazawa F, Aono H, Kimura T.
    J Rheumatol; 2001 Jan; 28(1):22-8. PubMed ID: 11196534
    [Abstract] [Full Text] [Related]

  • 3. The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis.
    Pierer M, Brentano F, Rethage J, Wagner U, Hantzschel H, Gay RE, Gay S, Kyburz D.
    Rheumatology (Oxford); 2007 Jul; 46(7):1063-70. PubMed ID: 17426140
    [Abstract] [Full Text] [Related]

  • 4. Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis.
    Neidhart M, Wehrli R, Brühlmann P, Michel BA, Gay RE, Gay S.
    Arthritis Rheum; 1999 Apr; 42(4):622-30. PubMed ID: 10211875
    [Abstract] [Full Text] [Related]

  • 5. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G, Studnicka-Benke A, Witzmann G, Höfler E, Smolen J.
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [Abstract] [Full Text] [Related]

  • 6. Soluble Fas ligand inhibits angiogenesis in rheumatoid arthritis.
    Kim WU, Kwok SK, Hong KH, Yoo SA, Kong JS, Choe J, Cho CS.
    Arthritis Res Ther; 2007 Mar; 9(2):R42. PubMed ID: 17459170
    [Abstract] [Full Text] [Related]

  • 7. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients.
    Kotake S, Udagawa N, Hakoda M, Mogi M, Yano K, Tsuda E, Takahashi K, Furuya T, Ishiyama S, Kim KJ, Saito S, Nishikawa T, Takahashi N, Togari A, Tomatsu T, Suda T, Kamatani N.
    Arthritis Rheum; 2001 May; 44(5):1003-12. PubMed ID: 11352231
    [Abstract] [Full Text] [Related]

  • 8. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
    Hayashi S, Miura Y, Nishiyama T, Mitani M, Tateishi K, Sakai Y, Hashiramoto A, Kurosaka M, Shiozawa S, Doita M.
    Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415
    [Abstract] [Full Text] [Related]

  • 9. Extravasation into synovial tissue induces CCL20 mRNA expression in polymorphonuclear neutrophils of patients with rheumatoid arthritis.
    Schlenk J, Lorenz HM, Haas JP, Herrmann M, Hohenberger G, Kalden JR, Röllinghoff M, Beuscher HU.
    J Rheumatol; 2005 Dec; 32(12):2291-8. PubMed ID: 16331752
    [Abstract] [Full Text] [Related]

  • 10. Interleukin 16 expression in relation to disease activity in rheumatoid arthritis.
    Blaschke S, Schulz H, Schwarz G, Blaschke V, Müller GA, Reuss-Borst M.
    J Rheumatol; 2001 Jan; 28(1):12-21. PubMed ID: 11196512
    [Abstract] [Full Text] [Related]

  • 11. Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis.
    Perlman H, Pagliari LJ, Liu H, Koch AE, Haines GK, Pope RM.
    Arthritis Rheum; 2001 Jan; 44(1):21-30. PubMed ID: 11212162
    [Abstract] [Full Text] [Related]

  • 12. Novel mechanisms of selective apoptosis in synovial T cells of patients with rheumatoid arthritis.
    Hoa TT, Hasunuma T, Aono H, Masuko K, Kobata T, Yamamoto K, Sumida T, Nishioka K.
    J Rheumatol; 1996 Aug; 23(8):1332-7. PubMed ID: 8856610
    [Abstract] [Full Text] [Related]

  • 13. Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis.
    Yamamura M, Kawashima M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M, Morita Y, Ohmoto Y, Makino H.
    Arthritis Rheum; 2001 Feb; 44(2):275-85. PubMed ID: 11229457
    [Abstract] [Full Text] [Related]

  • 14. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis.
    Ruth JH, Volin MV, Haines GK, Woodruff DC, Katschke KJ, Woods JM, Park CC, Morel JC, Koch AE.
    Arthritis Rheum; 2001 Jul; 44(7):1568-81. PubMed ID: 11465708
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Expression and localisation of the new metalloproteinase inhibitor RECK (reversion inducing cysteine-rich protein with Kazal motifs) in inflamed synovial membranes of patients with rheumatoid arthritis.
    van Lent PL, Span PN, Sloetjes AW, Radstake TR, van Lieshout AW, Heuvel JJ, Sweep CG, van den Berg WB.
    Ann Rheum Dis; 2005 Mar; 64(3):368-74. PubMed ID: 15485996
    [Abstract] [Full Text] [Related]

  • 17. Distinct effects of soluble and membrane-bound fas ligand on fibroblast-like synoviocytes from rheumatoid arthritis patients.
    Audo R, Calmon-Hamaty F, Papon L, Combe B, Morel J, Hahne M.
    Arthritis Rheumatol; 2014 Dec; 66(12):3289-99. PubMed ID: 25078097
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Galectin 3 and its binding protein in rheumatoid arthritis.
    Ohshima S, Kuchen S, Seemayer CA, Kyburz D, Hirt A, Klinzing S, Michel BA, Gay RE, Liu FT, Gay S, Neidhart M.
    Arthritis Rheum; 2003 Oct; 48(10):2788-95. PubMed ID: 14558084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.